Evidence map›Paper›PMID 39938479›Full record

ArticleImmunity2025

Cutting to the chase: Pruning alloreactive T cells.

Anita S Chong, Marlena Habal

Abstract read
In one paragraph

Article in Immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anita S ChongDepartment of Surgery, Section of Transplant, University of Chicago, Chicago, IL, USA. Electronic address: achong@uchicago.edu.
Marlena HabalDepartment of Medicine, Division of Cardiology, NYU Grossman School of Medicine, New York, NY, USA.

Funding

T cell mechanisms that distinguish robust tolerance from metastable allograft acceptance and failed tolerance (Project 2)P01AI097113 · NIAID · UNIVERSITY OF CHICAGO · PI Maria-Luisa Alegre, Anita S Chong · 2012 to 2026
$23.8M
Safety and efficacy of Belatacept in heart transplantationU01AI174997 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Marlena Habal · 2023 to 2026
$7.2M
Intrarenal B cells in acute kidney allograft rejectionR01AI148705 · NIAID · UNIVERSITY OF CHICAGO · PI CHONG, ANITA S, CLARK, MARCUS RAMSAY · 2020 to 2024
$4.0M
Mechanistic studies on pregnancy-induced humoral sensitization in organ transplantationR01AI182097 · NIAID · UNIVERSITY OF CHICAGO · PI Anita S Chong · 2024 to 2026
$2.5M
Deconstructing B cell transplantation toleranceR01AI142747 · NIAID · UNIVERSITY OF CHICAGO · PI CHONG, ANITA S · 2019 to 2022
$2.2M
NIAID NIH HHS P01 AI097113NIAID NIH HHS R01 AI142747NIAID NIH HHS R01 AI148705NIAID NIH HHS R01 AI182097NIAID NIH HHS U01 AI174997
6 · The paper itself

Abstract

Indirect CD4

Indexed as

CD4-Positive T-LymphocytesGraft RejectionAnimalsHistocompatibility Antigens Class IIHumansImmunodominant EpitopesIsoantibodiesHistocompatibility Antigens Class IIImmunodominant EpitopesIsoantibodies

Identifiers

PMID39938479
PMCPMC12121668

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.